(Q28378625)

English

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin (English)

0 references

0 references

1 reference

1 reference

H Tomioka

1

0 references

H Saito

series ordinal

2

0 references

K Sato

series ordinal

3

0 references

language of work or name

English

0 references

publication date

June 1993

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

37

0 references

issue

6

0 references

page(s)

1259-63

0 references

cites work

Mycobacteria and the new quinolones

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

20 March 2017

Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

20 March 2017

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

20 March 2017

Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

20 March 2017

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

20 March 2017

Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

29 September 2017

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

29 September 2017

Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

29 September 2017

In vitro activity of sparfloxacin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

29 September 2017

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

29 September 2017

Pharmacokinetics and tissue penetration of ciprofloxacin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

2 June 2018

Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

2 June 2018

Antimycobacterial activities of a new quinolone, sparfloxacin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187950

retrieved

2 June 2018

[In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8392307

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8392307

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8392307

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and tissue penetration of ofloxacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8392307

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.37.6.1259

0 references

PMC publication ID

187950

0 references

PubMed publication ID

8392307

0 references

(Q28378625)

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)